نتایج جستجو برای: پروتئین brca1

تعداد نتایج: 26041  

Journal: :Histology and histopathology 2009
A Mangia A Chiriatti S Tommasi F Menolascina S Petroni F A Zito G Simone F Schittulli A Paradiso

The aim of the study was to evaluate the performance of immunohistochemical MS110 expression in a series of familial and sporadic breast cancer patients. An immunohistochemical study was performed on TMA samples from 93 sporadic and 94 familial breast cancer patients with (7/94) and without BRCA1 germline mutations. BRCA1 protein expression level was evaluated using the monoclonal MS110 antibod...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2001
J D Parvin

T breastand ovarian-specific tumor suppressor protein, BRCA1, has been implicated in regulating the nuclear processes of repair of damaged DNA, chromatin remodeling, and transcription. Although many have sought specific DNA sequences bound by BRCA1, no such sequences have been reported. In new research described in this issue of PNAS (1), BRCA1 protein is shown to bind to DNA with high affinity...

Journal: :Cell 2001
Sharon B. Cantor Daphne W. Bell Shridar Ganesan Elizabeth M. Kass Ronny Drapkin Steven Grossman Doke C.R. Wahrer Dennis C. Sgroi William S. Lane Daniel A. Haber David M. Livingston

BRCA1 interacts in vivo with a novel protein, BACH1, a member of the DEAH helicase family. BACH1 binds directly to the BRCT repeats of BRCA1. A BACH1 derivative, bearing a mutation in a residue that was essential for catalytic function in other helicases, interfered with normal double-strand break repair in a manner that was dependent on its BRCA1 binding function. Thus, BACH1/BRCA1 complex for...

ژورنال: :بیماری های پستان 0
فاطمه کشاورزی دانشگاه آزاد اسلامی، واحد علوم و تحقیقات تهران غلام رضا جوادی دانشگاه آزاد اسلامی، واحد علوم و تحقیقات تهران ناهید نفیسی مرکز تحقیقات سرطان پستان دانشگاه علوم پزشکی شهید بهشتی کیوان مجیدزاده مرکز تحقیقات سرطان پستان جهاد دانشگاهی واحد علوم پزشکی تهران وحید رضا یاسایی مرکز تحقیقات ژنومیک دانشگاه علوم پزشکی شهید بهشتی حمیده باقریان مرکز تحقیقات ژنتیک انسانی کوثر، آزمایشگاه ژنتیک پزشکی دکتر زینلی محمدرضا مشایخی

مقدمه : جهش های ژن brca1 (breast cancer susceptibility gene1) تقریباً در 50 درصد خانواده های با ظهور زودهنگام سرطان پستان و 80 درصد خانواده های با ظهور زودهنگام سرطان پستان - تخمدان و جهش های ژن brca2(breast cancer susceptibility gene2) نیز در درصدی از موارد سرطان پستان ارثی وجود دارند. لذا از آنجا که جهش های این دو ژن بر مدیریت بالینی افراد درمعرض خطر اثر دارد، غربالگری آنها رو به افزایش است. ب...

ژورنال: :مجله علمی دانشگاه علوم پزشکی گرگان 0
حسین تیموری h.teimori (m.sc) department of genetic , gorgan university of medical sciencesدانشکده پزشکی گرگان ، تلفن : 6-2241655-0171 دکتر پروین مهدی پور p .mehdipour (ph.d) دکتر مرتضی عطری m atri (m .d) محمد رضا میرزایی m.r.mirzai (m.sc)

سرطان پستان یکی از شایع ترین علل مرگ در میان زنان مبتلا به سرطان می باشد. بیش از نیمی از خانواده های دارای سرطان پستان فامیلی در ژن مستعد کننده به سرطان، معروف به brca1 جهش نشان می دهند. در این مطالعه نمونه خود 30 زن مبتلا به سرطان پستان که سابقه فامیلی در بروز بیمار داشتند، مورد بررسی قرار گرفت. روش غیر رادیواکتیو pcr-sscp به منظور تشخیص جهش زایی در اگزون های 3، 10 و 12 ژن brca1 مورد استفاده و...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Sara Alvarez Ramon Diaz-Uriarte Ana Osorio Alicia Barroso Lorenzo Melchor Maria Fe Paz Emiliano Honrado Raquel Rodríguez Miguel Urioste Laura Valle Orland Díez Juan Cruz Cigudosa Joaquin Dopazo Manel Esteller Javier Benitez

The genetic changes underlying in the development and progression of familial breast cancer are poorly understood. To identify a somatic genetic signature of tumor progression for each familial group, BRCA1, BRCA2, and non-BRCA1/BRCA2 (BRCAX) tumors, by high-resolution comparative genomic hybridization, we have analyzed 77 tumors previously characterized for BRCA1 and BRCA2 germ line mutations....

Journal: :Cancer research 2004
Insoo Bae Saijun Fan Qinghui Meng Jeong Keun Rih Hee Jong Kim Hyo Jin Kang Jingwen Xu Itzhak D Goldberg Anil K Jaiswal Eliot M Rosen

Mutations of the breast cancer susceptibility gene 1 (BRCA1), a tumor suppressor, confer an increased risk for breast, ovarian, and prostate cancers. To investigate the function of the BRCA1 gene, we performed DNA microarray and confirmatory reverse transcription-PCR analyses to identify BRCA1-regulated gene expression changes. We found that BRCA1 up-regulates the expression of multiple genes i...

2014
Artem V. Kononenko Ruchi Bansal Nicholas C.O. Lee Brenda R. Grimes Hiroshi Masumoto William C. Earnshaw Vladimir Larionov Natalay Kouprina

BRCA1 is involved in many disparate cellular functions, including DNA damage repair, cell-cycle checkpoint activation, gene transcriptional regulation, DNA replication, centrosome function and others. The majority of evidence strongly favors the maintenance of genomic integrity as a principal tumor suppressor activity of BRCA1. At the same time some functional aspects of BRCA1 are not fully und...

Journal: :Molecular cancer research : MCR 2011
Paola De Luca Elba S Vazquez Cristian P Moiola Florencia Zalazar Javier Cotignola Geraldine Gueron Kevin Gardner Adriana De Siervi

BRCA1 plays numerous roles in the regulation of genome integrity and chemoresistance. Although BRCA1 interaction with key proteins involved in DNA repair is well known, its role as a coregulator in the transcriptional response to DNA damage remains poorly understood. In this study, we show that BRCA1 plays a central role in the transcriptional response to genotoxic stress in prostate cancer. BR...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Barbara Quaresima Francesco Romeo Maria C Faniello Maddalena Di Sanzo Chang-Gong Liu Annamaria Lavecchia Cristian Taccioli Eugenio Gaudio Francesco Baudi Francesco Trapasso Carlo M Croce Giovanni Cuda Francesco Costanzo

PURPOSE The aim of this study was to explore the gene expression pattern produced by the cancer-associated BRCA1 5083del19 founder mutation by using a microarray analysis. Such a mutation, identified in a subset of familial breast cancer patients, involves a deletion at the 3' end of the BRCA1 messenger leading, in the mature protein, to the ablation of the BRCT tandem domain. EXPERIMENTAL DE...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید